[23 varieties included in the new batch of nationally organized high-value medical consumables] According to the National Medical Insurance Administration, on September 10th, the seventh batch of nationally organized centralized bulk procurement of medical consumables (hereinafter referred to as "collective procurement") opened bids in Tianjin and produced winning results. This collection included 23 types of digestive interventional medical consumables. A total of 558 products from 156 companies submitted bids, and 517 products from 148 companies were selected. Most of the mainstream products in clinical use were selected. Digestive interventional medical consumables are mainly used for endoscopic surgical treatment of digestive tract diseases, covering clinical treatment scenarios such as bile and pancreatic stones, gastrointestinal polyps and tumors, and gastrointestinal bleeding. They have large clinical usage, many product models, and large differences in usage for different surgeries. After centralized procurement, the overall cost burden of digestive interventional treatment will be reduced. Judging from the bidding results, mainstream clinical products were generally selected. For example, 32 companies submitted bids for digestive interventional injection needles with an annual clinical use of more than 2 million, and 21,578 companies were selected; 69 companies submitted bids for digestive interventional lithotomy baskets with the largest number of manufacturers, and 64 companies were selected. In addition, coated intestinal stents and multi-stage expansion balloon catheters with special functions were selected by 15 companies, reflecting the clinical value of the products.